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The mosquito Aedes aegypti is a potent vector of the
chikungunya, yellow fever, and dengue viruses,
responsible for hundreds of millions of infections
and over 50,000 human deaths per year. Mutagen-
esis in Ae. aegypti has been established with
TALENs, ZFNs, and homing endonucleases, which
require the engineering of DNA-binding protein
domains to provide genomic target sequence speci-
ficity. Here, we describe the use of the CRISPR-
Cas9 system to generate site-specific mutations in
Ae. aegypti. This system relies on RNA-DNA base-
pairing to generate targeting specificity, resulting in
efficient and flexible genome-editing reagents. We
investigate the efficiency of injection mix composi-
tions, demonstrate the ability of CRISPR-Cas9 to
generate different types of mutations via disparate
repair mechanisms, and report stable germline
mutations in several genomic loci. This work offers
a detailed exploration into the use of CRISPR-Cas9
in Ae. aegypti that should be applicable to non-
model organisms previously out of reach of genetic
modification.
INTRODUCTION
As a primary vector of the serious and sometimes fatal chikungu-
nya, yellow fever, and dengue viruses, the mosquito Aedes
aegypti (Ae. aegypti) is responsible for hundreds ofmillions of hu-
man infections annually (Bhatt et al., 2013). To transmit disease,
a female mosquito must bite an infected individual, and, after a
period of viral incubation within the mosquito, bite and infect
another human. Female mosquitoes use cues such as odor, car-
bon dioxide, and temperature to locate a host and obtain a
blood-meal (McMeniman et al., 2014), which is used to produce
a clutch of approximately 100 eggs. Once a mosquito has devel-
oped mature eggs, she uses volatile and contact cues to locate
and evaluate a body of water at which to lay her eggs. Our long-
term goal is to use genome-engineering techniques coupledwith
quantitative behavioral analysis to investigate the genetic and
neural bases of innate chemosensory behaviors in this important
disease vector.Clustered regularly interspaced palindromic repeats (CRISPR)
and CRISPR-associated (Cas) genes are components of an
adaptive immune system that are found in a wide variety of bac-
teria and archaea (Doudna and Charpentier, 2014). Beginning in
late 2012 (Jinek et al., 2012), the bacterial type II CRISPR-Cas9
system was adapted as a genome-engineering tool in many
different organisms and in vitro preparations, dramatically ex-
panding the ability tomodify genomes (Doudna and Charpentier,
2014). The ease of designing and generating these reagents at
the bench has opened the door for studies of gene function in
non-traditional model organisms.
The genome of Ae. aegypti is relatively large and incompletely
mapped (Juneja et al., 2014; Nene et al., 2007; Timoshevskiy
et al., 2014), making it difficult to recover mutations generated
by traditional forward genetics. Ae. aegypti has a recent history
of genetic modification, including transposon-mediated trans-
genesis (Coates et al., 1998; Lobo et al., 2002) and loss-of-func-
tion gene editing with zinc-finger nucleases (ZFNs) (DeGennaro
et al., 2013; Liesch et al., 2013; McMeniman et al., 2014), TAL-
effector nucleases (TALENS) (Aryanet al., 2013a, 2014), andhom-
ing endonuclease genes (HEGs) (Aryan et al., 2013b). ZFNs and
TALENs are modular DNA-binding proteins tethered to a non-
specific FokI DNA nuclease (Carroll, 2014), while HEGs are natu-
rally occurring endonucleases that can be reengineered to target
novel sequences (Stoddard, 2014). Targeting specificity by these
reagents is conferred by context-sensitive protein-DNA-binding
interactions, and these proteins can be difficult to engineer.
Here we describe methods for site-directed mutagenesis in
Ae. aegypti using RNA-guided endonucleases based on the
type II CRISPR-Cas9 system. The double-stranded endonuclease
Cas9 derived from Streptococcus pyogenes uses RNA-DNA
Watson-Crick base-pairing to target to specific genomic loca-
tions. This system has been adapted for precision genome engi-
neering in dozens of organisms frombacteria to primates (Doudna
andCharpentier, 2014;Penget al., 2014). Inparticular, twostudies
in thevinegarflyDrosophilamelanogaster (Bassett etal., 2013) and
the zebrafish Danio rerio (Hwang et al., 2013) were important in
guiding our early attempts to adapt CRISPR-Cas9 to Ae. aegypti.
A detailed bench manual with step-by-step guidance for
designing, generating, and testing these reagents in mosquitoes
is available as Data S1. Given the proven flexibility of this system,
we believe that the protocols and procedures outlined here and
by numerous other laboratories will continue to be optimized and
modified for use in many organisms for which precision genome
engineering has not yet been employed.Cell Reports 11, 51–60, April 7, 2015 ª2015 The Authors 51
RESULTS
Outline of CRISPR-Cas9 System and Injection
Components
The core of the CRISPR-Cas9 system has two components as
follows: (1) a synthetic single guide RNA (sgRNA), which is a
small RNA containing 17–20 bases of complementarity to a spe-
cific genomic sequence; and (2) the Cas9 nuclease derived from
Streptococcus pyogenes (SpCas9). SpCas9 forms a complex
with the sgRNA and induces double-stranded DNA breaks at se-
quences of the genome that are directly 50 to a protospacer-
adjacent motif (PAM) and are complementary to the sgRNA
recognition site. The PAM sequence for SpCas9 is NGG, which
occurs approximately once every 17 bp in the Ae. aegypti
genome, making it possible to target essentially any locus. All
work in this paper utilizes SpCas9, which is henceforth referred
to simply as Cas9.
To generate stable germline mutations, CRISPR-Cas9 re-
agents are injected into pre-blastoderm-stage embryos
composed of a syncytium of nuclei prior to cellularization that
offers access of genome-editing reagents to the nuclei of both
somatic and germline cells. Embryos are microinjected 4–8 hr
after egg laying, and allowed to develop for 3 days before
being hatched in a deoxygenated hatching solution (Lobo
et al., 2006). G0 pupae are collected for sequencing to deter-
mine genome modification rates, or are allowed to emerge as
adults and outcrossed to wild-type LVP-IB12 mosquitoes.
Following blood-feeding, G1 eggs are collected from these
outcrosses to screen for germline transmission of stable
mutations.
When faced with a double-stranded DNA break, DNA repair
machinery can resolve this break in one of two ways as follows:
(1) non-homologous end joining, which can result in small inser-
tions and deletions; or, less frequently, (2) homology-directed
repair, which uses exogenous sequences containing regions of
homology surrounding the cut site as a template for repair. Cut-
ting with multiple sgRNAs can result in large deletions between
the two cut sites. In this paper, we discuss stable germline trans-
mission of all three types of alleles in Ae. aegypti.
Identifying Optimal Injection Mixes for CRISPR-Cas9
Mutagenesis
Insertions and deletions resulting from non-homologous end
joining are a proxy for the activity of a particular sgRNA/Cas9
combination and can be detected by Surveyor or T7 Endonu-
clease I (T7E1) (Reyon et al., 2012), high-resolution melting point
analysis (HRMA) (Dahlem et al., 2012), Sanger sequencing
(Brinkman et al., 2014), or deep sequencing (Gagnon et al.,
2014). Each of these techniques evaluates the level of polymor-
phism in a short PCR-generated amplicon surrounding the
sgRNA target site. With the exception of deep sequencing, these
approaches provide only semiquantitative estimates of the
mutagenesis in each sample, and, furthermore, HRMA and
Surveyor/T7E1 are prone to false positives because the
Ae. aegypti genome is highly polymorphic.
We used deep sequencing of barcoded PCR amplicons sur-
rounding putative CRISPR-Cas9 cut sites from small pools of
injected animals to accurately determine the rates of cutting at52 Cell Reports 11, 51–60, April 7, 2015 ª2015 The Authorsdifferent genomic loci. Sequencing libraries were prepared using
a two-step PCR process that incorporates adaptor and barcode
sequences necessary for Illumina sequencing (Figure 1A). To
minimize the underestimation ofmutagenesis rate due to deleted
primer-binding sequences, we designed a forward primer
50–100 bp from the predicted sgRNA cut site and a reverse
primer >50 bp on the opposite side. We estimated that
10,000–100,000 reads per sample were ample for this analysis,
so sequencing of amplicons from three sgRNAs per gene, for
ten different genes, costs approximately $70 per gene at current
pricing (MiSeq v3 reagents, 150-cycle flowcell, item MS-102-
3001). In our judgment, this method is cost-effective and pro-
vides high resolution relative to all other techniques.
Following sequencing, reads were aligned to a reference
sequence using the GSNAP short read aligner (Wu and Nacu,
2010), and analyzed with the python package pysamstats. This
procedure reveals the number of polymorphisms, including in-
sertions and deletions, found in reads that span each nucleotide
of a reference sequence (Figure 1B). In injections containing a
sgRNA and Cas9, a pattern of elevated insertions and deletions
can be observed with a peak 3 bp 50 of the beginning of the
PAM, exactly the position at which Cas9 is known to make a
double-stranded break (Figure 1C). Importantly, there was high
concordance in themutagenesis rates amongmultiple biological
replicates (Figure 1C).
We next varied the delivery method and concentration of
Cas9, and the concentration of a given sgRNA, to determine
an optimal injectionmix. A DNA plasmid that expresses Cas9 un-
der the control of the Ae. aegypti polyubiquitin (PUb) promoter
did not induce detectable rates of insertions or deletions
with a validated sgRNA (data not shown). When included at
500 ng/ml, both Cas9 mRNA and recombinant Cas9 protein
induced detectable mutagenesis at two distinct guide RNA sites.
However, Cas9 protein induced mutagenesis at rates five to ten
times higher than Cas9 mRNA (Figure 1D). To test whether the
concentration of sgRNA or Cas9 mRNA or protein was limiting
in these earlier injections, we tried four additional injection mixes
with a single validated sgRNA (Figure 1E), and determined that
mixes containing 400 ng/ml Cas9 recombinant protein induced
the highest rates of mutagenesis. Increasing sgRNA concentra-
tion did not dramatically increase mutagenesis rates.
Identifying Active sgRNAs for a Given Genomic Target
We reasoned that sgRNAs causing higher somatic cut rates
would be more likely to result in stable germline mutations. We
manually searched six different genes for sgRNAs composed
of 17–20 bases (Fu et al., 2014) adjacent to a PAM and beginning
with GG or G to facilitate in vitro transcription. We then selected
three sgRNAs per gene with a low probability of off-target bind-
ing (Figure 2A; Table S1).
To test the efficiency of these sgRNAs, we performed a series
of six small test injections of recombinant Cas9 protein at
333 ng/ml and a pool of three sgRNAs (40 ng/ml each), each tar-
geting a different gene, into 145–168 Ae. aegypti embryos (Fig-
ure 2B). Survival rateswere very high for these injections (ranging
from 46.1%–63.3%, as compared to 18.6% average survival
with 500 ng/ml Cas9 protein or mRNA). We attribute this marked
increase in survival to the reduction in Cas9 concentration.
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Figure 1. Deep Sequencing to Quantify CRISPR-Cas9 Efficiency
(A) Schematic of PCR amplicon barcoding.
(B and C) Amplicons generated from adults reared from embryos injected with 333 ng/ml Cas9 protein and 40 ng/ml sgRNA (AAEL004091-sgRNA1) using primers
AAEL004091-1-F and AAEL004091-1-R. (B) Visualization of a subset of alignments to the amplicon reference sequence (top) and (C) quantification of three
replicate libraries as percentage of reads aligned to a given base that contain an insertion or deletion at that base.
(D and E) Summary of sequencing data from animals injected with two different sgRNAs in combination with Cas9mRNA (left) or Cas9 recombinant protein (right),
at the indicated concentrations; n = 7–18 libraries (D) and n = 2 libraries (E). Data are plotted as mean (circle) and 95% confidence intervals (line).Surviving embryos were reared to pupal stages and collected for
sequencing of PCR amplicons (Figure 2B).
All 18 sgRNAs induced detectable levels of mutagenesis,
which varied within and among different genomic targets (Fig-
ure 2C), reflecting sequence- or context-dependent effects on
sgRNA efficiency that are not yet fully understood. Designing
and testing three sgRNAs resulted in the identification of at least
one highly active sgRNA for the six genomic targets tested here.
Users are strongly advised to test multiple sgRNAs per gene
before undertaking large-scale mutagenesis injections.
Germline Transmission of Mutant Alleles
We next examined whether somatic mutagenesis detected in
adults reared from injected embryos (G0 animals) resulted inthe transmission of stable mutant alleles through the germline
to their offspring (G1 animals). We designed an sgRNA near the
50 end of Aaeg-wtrw, and included 300 ng/ml of a 200-bp sin-
gle-stranded DNA oligodeoxynucleotide (ssODN) donor as a
template for homology-directed repair. The ssODN had homol-
ogy arms of 87–90 bases on either side of the Cas9 cut site,
flanking an insert with stop codons in all three frames of transla-
tion and a restriction enzyme site. Successful integration of this
template would truncate the full-length protein of 908 amino
acids at 91 amino acids (Figure 3A).
Embryos (n = 636) were injected with a mixture of 200 ng/ml
Cas9 mRNA and 12.5 ng/ml sgRNA (these injections were per-
formed prior to the optimization of injection mixes described
above). We performed amplicon sequencing on six pools ofCell Reports 11, 51–60, April 7, 2015 ª2015 The Authors 53
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Figure 2. Identifying Active sgRNAs
(A) Schematic of two target genes in the Ae. aegypti genome indicating the three sgRNAs designed in the first exon of each gene.
(B) Schematic of the workflow for a small injection (approximately 150 embryos) of Cas9 protein and a pool of three sgRNAs against three distinct target genes.
(C) Sequencing results from six small injections (sgRNA sequences can be found in Table S1); n = 3 sequencing libraries per sgRNA. Data are presented asmeans
and 95% confidence intervals.five to six adult G0 animals after they were outcrossed and
allowed to lay eggs (Figure 3B). These samples contained a
maximum mutation rate of 24.87% centered on the Cas9 cut
site (Figure 3C). Amplicons derived from animals injected with
an sgRNA targeting a different region of the genome contained
no detectable insertions or deletions at the Aaeg-wtrw locus
(Figure 3C). On average 0.71%of aligned reads from six samples
contained sequences corresponding to the single-stranded DNA
donor (Figure 3D), indicating that the ssODN template could
drive homology-directed repair in somatic tissue, albeit at a
much lower frequency than insertions or deletions mediated by
non-homologous end joining.
To determine whether these mutations were stably trans-
mitted through the germline, we sequenced PCR amplicons
derived from 62 pools each containing five male and five female
G1 offspring. Analysis of resulting insertions and deletions using
the Genome Analysis Toolkit [GATK (DePristo et al., 2011)] re-
vealed at least 117 mutant chromosomes spread across
50 pools. Given that each G1 individual can only carry a single
mutant chromosome, we concluded that the G1 mutation rate
was at least 117/620 or 18.9% (Figure 3E). Four of these alleles
corresponded perfectly to the sequence of the ssODN, so our
rate of stable germline transmission of alleles generated by ho-
mology-driven repair was at least 0.6% (Figure 3E). This is similar
to rates in G0 animals (Figures 3D and 3E), suggesting that
somatic mutagenesis can predict the efficiency of germline
mutagenesis.54 Cell Reports 11, 51–60, April 7, 2015 ª2015 The AuthorsWe hatched F2 eggs from a single family containing an
allele generated by homology-directed repair. Sequencing of
single-pair crosses allowed us to isolate a stable mutant
line that could be genotyped by the ssODN-introduced restric-
tion site (Figure 3F). This line was outcrossed for eight
generations to wild-type mosquitoes to increase genetic diver-
sity and reduce the possibility of retaining off-target mutations.
The presence of the mutant allele was verified in individual
female mosquitoes at each generation by molecular genotyp-
ing, and eggs were hatched from heterozygous mutant females
only.
Deletions Induced by Multiplexed sgRNAs
Double-stranded breaks induced at multiple sgRNA sites
can induce large deletions between the two cut sites in
D. melanogaster (Ren et al., 2013). We performed a series of
five injections into small numbers of embryos using sgRNAs
targeting three different genes. All but one of these sgRNAs
(AAEL000926-sgRNA4) was validated previously (Figure 2C),
and injection mixes also included ssODN donors (Figure 4A;
Data S2). G1 embryos were hatched and screened as individual
families derived from a single female G0 (Figure 4B). We identi-
fied mutant families by screening PCR amplicons generated
from pools of G1 male pupae for size-shifted bands. Following
outcrossing and egg collection, individual G1 females were
similarly genotyped by PCR amplicon size (Figures 4C–4E) to
estimate mutation rates.
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Figure 3. Germline Transmission of Mutant Alleles
(A) Schematic of the Ae. aegypti wtrw locus, detailing the sgRNA-binding site, ssODN donor, and modified locus.
(B) Schematic of injection performed to isolate mutations.
(C) Summary sequencing data from G0 adults; n = 6 (wtrw) and n = 3 (off-target), presented as means (circle) and 95% confidence intervals (lines).
(D) Exogenous ssODN sequence that was used as a query for the unix tool grep (left) and reads containing perfect homology-directed repair presented as a
boxplot (right, box represents median and first and third quartiles, whiskers represent data range).
(E) Summary of G0 and G1 sequencing results.
(F) Restriction enzyme diagnostic of ssODN insertion.We found a wide range of mutant transmission rates in families
derived fromsingleG0 individuals (Figure 4D). Sanger sequencing
of some bands revealed that mutations ranged from simple dele-
tions, to homology-directed repair from the ssODN donor, to
more complex modifications, including polymorphisms, inver-
sions, and duplications. Additionally, we were successful in ob-
taining germline mutations at high rates in each of three small
injections (Figure 4E), making this a cost-effective and efficient
way to generate loss-of-function mutant alleles. The relatively
large size of deletions generated by this method simplifies
sized-basedmolecular genotyping of females at eachgeneration.Integration and Transmission of Large Fluorescent
Cassettes
Finally, we asked whether CRISPR-Cas9 could be used to
introduce gene cassettes via homology-dependent repair.
Previously, ZFNs were used to introduce large cassettes into
Ae. aegypti from a plasmid DNA donor with homology arms of
at least 800 bp on either side (Liesch et al., 2013; McMeniman
et al., 2014), generating a null mutant by the insertion of a visible
fluorescent reporter. We performed injections with Cas9 protein,
a validated sgRNA, and a plasmid donor containing homology
arms of 799 bp and 1,486 bp. This plasmid (Addgene 47917)Cell Reports 11, 51–60, April 7, 2015 ª2015 The Authors 55
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(A) Schematic of the AAEL010779 genomic locus, detailing the design of two sgRNAs and an ssODN donor.
(B) Injection strategy to identify deletion events in G1 animals with the injection of a small (125–150) number of embryos.
(C) Example agarose gel of nine G1 female offspring of a single G0 female reveals four wild-type and five heterozygous individuals.
(D) Percentage of mutant AAEL010779 G1 females from the ten G0 families identified as containing at least one mutant allele is presented as a boxplot (box
represents median and first and third quartiles, whiskers represent data range).
(E) Summary data of G1 mutagenesis from three injections of this type.contains a cassette comprising the constitutive PUb promoter
driving the expression of the fluorescent reporter ECFP (Figures
5A and 5B). Arms were cloned fromwild-type LVP-IB12 mosqui-
toes and were designed to avoid repetitive sequences such as
transposable elements. Following injection, individual female
G0 animals were outcrossed to wild-type mosquitoes and G1
eggs were collected (Figure 5A). Because we previously
observed that successful homology-directed repair occurs pri-
marily, if not exclusively, in female G0 Ae. aegypti, we discarded
G0 males and screened G1 families generated from females.
G1 larvae at 3–5 days post-hatching were screened under a
fluorescence dissecting microscope for the fluorescent protein
expressed under control of the PUb promoter (Figure 5C). Fluo-
rescent individuals were collected, reared to adulthood, and
crossed to wild-type animals to establish stable lines. To verify
gene-specific insertion of our cassette, we designed PCR
primers spanning both homology arms (Figure 5C). It is critical
that these primers are designed outside each arm and that
bands obtained are sequenced to verify junctions between
genomic and exogenous sequence on each end of the
insertion.
Lines containing verified targeted insertions were outcrossed
to wild-type mosquitoes for eight generations by selecting fluo-
rescent larvae and pupae. A homozygous line was established
by mating heterozygotes. Putative homozygous mosquitoes
were selected by increased fluorescence as larvae, separated56 Cell Reports 11, 51–60, April 7, 2015 ª2015 The Authorsby sex, and used to establish single-pair matings. The genotype
of these single-pair matings was verified by PCR (Figure 5D).
We generated verified targeted insertions in two of four
genomic loci with the Ae. aegypti PUb promoter driving the
expression of ECFP (Figure 5; Table S3) or dsRed (Table S3),
suggesting that homology-directed repair with large plasmid
donors occurs at a relatively low frequency compared to other
forms of CRISPR-Cas9-mediated genome modification. A
drastic variance in the efficiency noted in two injections
(Table S3) suggests that simple modifications of injection mix
component concentration may increase integration rates,
perhaps at the expense of embryo survival. The identification
of stably transmitting integration events at non-targeted
genomic loci underscores the necessity of verifying all lines
generated by this technique by PCRor othermolecular methods.
DISCUSSION
We have demonstrated that the CRISPR-Cas9 system is a highly
effective tool for precision genome editing in the mosquito
Ae. aegypti. Compared to the relatively low throughput and
high cost of ZFN- and TALEN-mediated mutagenesis, the ease
of designing and producing CRISPR-Cas9 reagents has allowed
us to generate stable and precise loss-of-function mutations in
five genes described here. A variety of mutant alleles can be
recovered, including frameshift mutations caused by insertions
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Figure 5. Insertion of Fluorescent Cassettes by Homology-Directed Repair
(A) Schematic of injection and screening strategies to obtain alleles with an insertion of an ECFP cassette (blue).
(B) Design of the plasmid donor.
(C) At left, bright-field and ECFP fluorescence images of two pupae: wild-type (top) andAAEL000582ECFP/ECFP (bottom); scale bar, 1mm. At right and below, PCR
strategy to verify directed insertion of the PUb-ECFP cassette.
(D) PCR strategy to identify homozygous individuals. See also Table S3.or deletions, deletion of a region between two sgRNA target
sites, and integration of exogenous sequences from a single-
stranded oligonucleotide or a double-stranded plasmid DNA
donor. This protocol provides a step-by-step manual to muta-
genesis in Ae. aegypti and also provides general principles that
will be useful when translated to other species.
Optimal Injection Mix
We recommend recombinant Cas9 protein for its reproducibility,
increased rates of mutagenesis, and embryo survival. It is likely
more stable than mRNA, both at the bench and in injected em-
bryos, andmay form a complex with sgRNA in vitro prior to injec-
tion. This can stabilize sgRNA/Cas9complexes (Jinek et al., 2014)
and ensuresmutagenesis without the delay of translation of Cas9
mRNA in theembryo. The specific concentrations suggestedhere
represent a good trade-off between survival and efficiency in ourhands. However, further modifications to this protocol may result
in significant increases in certain types of repair.
We recommend the following injection mix for Ae. aegypti
embryos (this may be a good starting point for other insect
embryos): 300 ng/ml recombinant Cas9 protein; 40 ng/ml sgRNA
(each); and 200 ng/ml ssODN or 500 ng/ml double-stranded
plasmid DNA (optional).
Designing Active sgRNAs
As in other organisms and cell lines (Fu et al., 2014; Ren et al.,
2014), we observed success with sgRNAs ranging in length
from 17 to 20 bp. However, different sgRNAs varied signifi-
cantly in effectiveness, even when targeted to a small region
of the same gene (Figure 2). Additionally, a single genomic
target (AAEL001123) was resistant to mutagenesis with six
different sgRNAs. Further experiments will determine whetherCell Reports 11, 51–60, April 7, 2015 ª2015 The Authors 57
sgRNA base composition (such as GC content) (Ren
et al., 2014) or underlying chromatin state (Wu et al., 2014)
influence efficacy. To maximize the chance of successful
mutagenesis, we recommend designing and testing multiple
sgRNAs targeting a given gene before committing to large-
scale injections.
Off-Target Effects
Off-target effects are a concern with any genome-editing tech-
nology, and we addressed these concerns in our experiments in
four ways. First, we checked sgRNA specificity using publicly
available bioinformatic tools (Hsu et al., 2013; Hwang et al.,
2013; Sander et al., 2010), selecting the most specific sgRNAs
within the region we wished to target. No obvious correlation
was detected between the cut rate and the predicted specificity
of the sgRNA (Figure 2C; Table S1), with the caveat that we did
not screen for mutagenesis at predicted off-target binding
sites. Second, we could generate mutant alleles with different
sgRNAs and test phenotypes in heteroallelic combination,
reducing the likelihood of shared off-target mutations. Third,
we successfully used truncated (<20 bp) sgRNAs, which have
been shown in cell culture to reduce the likelihood of off-target
modifications (Fu et al., 2014). Finally, all lines were outcrossed
to wild-type mosquitoes for at least eight generations to reduce
co-inheritance of all but the most tightly linked off-target
mutations. While these guidelines reduce the likelihood of off-
target mutagenesis, there is a need for continued efforts to
improve and verify the specificity of all genome-engineering
technologies.
Enhancing the Efficiency of Homology-Directed Repair
In our experiments, insertions and deletions mediated by non-
homologous end joining occurred at a much higher frequency
than by homology-directed repair. This is similar to what has
been observed in Ae. aegypti with other genome-editing tools,
such as ZFNs (Liesch et al., 2013; McMeniman et al., 2014),
and in other organisms, such as D. melanogaster (Gratz et al.,
2014).
Several approaches have been developed to increase rates
of homology-directed repair. These include injections in the
background of a DNA ligase 4 mutation (Beumer et al., 2013b,
2013a), or schemes that linearize a double-stranded donor
template in vivo. Finally, many laboratories working with
D. melanogaster have developed transgenic strains that express
Cas9 protein under ubiquitous or germline promoters, generally
improving the efficiency of mutagenesis and specifically
increasing rates of homology-directed repair (Gratz et al.,
2014; Ren et al., 2014). It remains to be seen whether transgenic
Cas9 delivery or alternative integration approaches can be
effectively implemented in Ae. aegypti.
We note that we observed a single round of injection that
resulted in high (>30%) rates of homology-directed repair but
extremely low survival (Table S3). This suggests that we might
achieve improvements in insertion efficiency by continuing to
modulate the composition of the injection mix. If the rates of ho-
mology-directed repair can be sufficiently improved, CRISPR-
Cas9 coupled with homology-directed repair will likely prove to
be a versatile tool to tag gene products and introduce trans-58 Cell Reports 11, 51–60, April 7, 2015 ª2015 The Authorsgenes into specific genomic loci, enabling the study of identified
neural circuits and other subsets of cells.
Conclusion
Precision genome engineering in mosquitoes holds great prom-
ise for studies on the genetic basis of behavior (DeGennaro et al.,
2013; Liesch et al., 2013; McMeniman et al., 2014), and for ge-
netic strategies to control vector population or disease compe-
tence (Alphey, 2014). Ongoing efforts to increase the specificity
and efficiency of these technologies is critical to their adaptation
as routine techniques, and we believe that the protocols outlined
here havemet those criteria for the generation of loss-of-function
mutations in the mosquito Ae. aegypti. Reagents based on
CRISPR-Cas9 have been used successfully in organisms from
bacteria to primates. This suggests that the techniques
described here can likely be adapted to many other non-model
organisms, as long as efficient methods for introducing the
reagents into the germline and screening for mutations can be
developed.
EXPERIMENTAL PROCEDURES
All laboratory blood-feeding procedures with mice and humans were
approved and monitored by The Rockefeller University Institutional Animal
Care and Use Committee (11487 and 14756) and Institutional Review Board
(LVO-0652). All humans gave their informed consent to participate in mosquito
blood-feeding procedures. Detailed procedures are available as Supplemental
Experimental Procedures.
Cas9 mRNA and Protein
Cas9mRNA was transcribed from pMLM3613 (Addgene 42251) (Hwang et al.,
2013) using mMessage mMachine T7 Ultra Transcription kit (AM1345,
Life Technologies). Recombinant Cas9 protein was obtained commercially
(CP01, PNA Bio).
sgRNA Design and Construction
The sgRNAs were designed by manually searching genomic regions for the
presence of PAMs with the sequence NGG, where N is any nucleotide. We
required that sgRNA sequences be 17–20 bp in length, excluding the PAM,
and contain one or two 50 terminal guanines to facilitate transcription by T7
RNA polymerase. sgRNA sequences were checked for potential off-target
binding using the following two web tools: http://zifit.partners.org/ZiFiT/ and
http://crispr.mit.edu. See Table S1 for sgRNA sequences and predictions of
off-target binding.
Extraction of Genomic DNA
Genomic DNA was extracted from individual or pools of mosquitoes using
either the DNEasy Blood and Tissue Kit (69581, QIAGEN) or a 96-well-plate
extraction protocol (Holleley and Sutcliffe, 2014).
Sequencing and Analysis of CRISPR-Cas9-Induced Mutations
A two-step PCR protocol was used to amplify amplicons surrounding the
putative CRISPR-Cas9 cut site from genomic DNA of G0 or G1 animals using
primers in Table S2. Libraries were sequenced on an Illumina MiSeq, aligned
to the wild-type reference sequence and examined for the presence of inser-
tions, deletions, or other polymorphisms. Scripts developed for the analysis of
this data are available at https://github.com/bnmtthws/crispr_indel.
Donor Construction for Homology-Directed Repair
The ssODNs were synthesized as 200-bp Ultramers (Integrated DNA Technol-
ogies). Homology arms for plasmid donorswere PCR-amplified from LVP-IB12
genomic DNA and cloned with In-Fusion HD cloning (Clontech Laboratories)
into PSL1180polyUBdsRED (Addgene 49327) or pSL1180-HR-PUbECFP
(Addgene 47917). Annotated sequences of oligonucleotides and plasmids
used for homology-directed repair are available in Data S2.
Molecular Genotyping of Stable Germline Alleles by PCR
To verify the presence of exogenous sequences inserted by homology-
directed repair, or the presence of insertions and deletions, PCR amplicons
surrounding the putative cut site were generated from genomic DNA (see
Table S2 for primer sequences). Purified amplicons were Sanger sequenced
(Genewiz), or used as a template for a restriction digest using BamHI
(R0136, New England Biolabs) or PacI (R0547, NEB).
Statistics
Summary data were plotted using the python packages matplotlib (boxplots)
and seaborn (means ± 95% confidence intervals).
Genotyping Stable Alleles by Fluorescence
Larvae or pupae were immobilized on a piece of moist filter paper and exam-
ined under a dissection microscope (SMZ1500, Nikon) with a fluorescent light
source and ECFP and dsRed filter sets.
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